Exploring heart rate variability as a biomarker for frailty: A narrative review
European Journal of Clinical Investigation · 2026-04 · 56 (4)
DOI: 10.1111/eci.70194 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 27.03.2026. Verfasst von Luca Tagliafico und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Geriatrics, Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Heart Rate, Frailty. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Frailty is defined as a state of increased vulnerability to stressors resulting from reduced physiological homeostasis. The need to identify biomarkers capable of offering insight into the biological underpinnings of frailty and supporting early detection, diagnosis, and prognostic evaluation has grown in recent years. Heart rate variability (HRV), defined as the temporal variability between consecutive R waves of the electrocardiogram (R‐R intervals), has emerged as a promising physiological biomarker in this context.
Methods
We conducted a narrative review of studies to synthesize evidence on HRV and frailty, examining analytical domains of HRV and situating findings within the current biomarker framework. Relevant literature was assessed across time‐domain, frequency‐domain, geometric and non‐linear measures of HRV, together with reported associations involving clinical, functional and cognitive outcomes.
Results
Within the landscape of frailty biomarkers, HRV provides a non‐invasive index of autonomic nervous system function. Reduced HRV has been associated with frailty status, diminished physiological reserve, adverse clinical outcomes, and cognitive decline, with particularly notable findings when assessed during physiological challenges rather than at rest. It should be noted, however, that the literature is heterogeneous and methodologically inconsistent, especially regarding recording duration and the specific HRV parameters analysed.
Conclusions
HRV is a highly promising physiological biomarker in the context of frailty, but further research is needed to clarify several aspects of its role. Its potential integration with other biomarkers may help confirm its validity and could contribute to identifying biomarker clusters relevant to personalized approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Geriatrics, Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
ORCID-Profile: Silvia Ottaviani, Stefania Peruzzo
Zitieren
APA
Tagliafico, L., Ottaviani, S., Balzano, R., Peruzzo, S., Nencioni, A., & Monacelli, F. (2026). Exploring heart rate variability as a biomarker for frailty: A narrative review. European Journal of Clinical Investigation, 56(4). https://doi.org/10.1111/eci.70194
Vancouver
Tagliafico L, Ottaviani S, Balzano R, Peruzzo S, Nencioni A, Monacelli F. Exploring heart rate variability as a biomarker for frailty: A narrative review. European Journal of Clinical Investigation. 2026;56(4). doi:10.1111/eci.70194
BibTeX
@article{Tagliafico2026,
author = {Tagliafico, Luca and Ottaviani, Silvia and Balzano, Riccardo and Peruzzo, Stefania and Nencioni, Alessio and Monacelli, Fiammetta},
title = {Exploring heart rate variability as a biomarker for frailty: A narrative review},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {4},
doi = {10.1111/eci.70194}
}
EUVIMED